Article
Extrapolating Vincristine-Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias.
CPT: pharmacometrics & systems pharmacology - 1 Aug 2026
Centanni Maddalena, van de Velde Mirjam Esther, Huitema Alwin D R, Kaspers Gertjan L, Karlsson Mats O, Friberg Lena E
Abstract excerpt
Vincristine is a cornerstone of pediatric chemotherapy, but its use is limited by vincristine-induced peripheral neuropathy (VIPN). Paradoxically, African children tolerate higher vincristine doses with minimal neurotoxicity, raising questions about the pharmacological mechanisms and model generalizability across populations. In this study, we re-estimated vincristine pharmacokinetic (PK) and PK-pharmacodynamic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
